Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferreri, A. J.M.
Right arrow Articles by Batchelor, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferreri, A. J.M.
Right arrow Articles by Batchelor, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 12 (June), 2003: 2407-2414
© 2003 American Society for Clinical Oncology


SPECIAL ARTICLES

Summary Statement on Primary Central Nervous System Lymphomas From the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002

Andrés J.M. Ferreri, Lauren E. Abrey, Jean-Yves Blay, Bettina Borisch, Jacob Hochman, Edward A. Neuwelt, Joachim Yahalom, Emanuele Zucca, Franco Cavalli, James Armitage, Tracy Batchelor

From the Department of Radiochemotherapy, San Raffaele H Scientific Institute, Milan, Italy; Departments of Neurology and Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neurology and Neurosurgery, Oregon Health & Science University, Portland, OR; College of Medicine, University of Nebraska Medical Center, Omaha, NE; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA; Unité Cytokines et Cancers, Hôpital E. Herriot & Centre Léon Bérard, Lyon, France; Department of Pathology, University of Geneva, Geneva; Oncology Institute of Southern Switzerland, Division of Medical Oncology, Ospedale San Giovanni, Bellinzona, Switzerland; and Department of Cell and Animal Biology, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Address reprint requests to Andrés J.M. Ferreri, MD, Department of Radiochemotherapy, San Raffaele H Scientific Institute, Via Olgettina 60, 20132, Milan, Italy; email: andres.ferreri{at}hsr.it.

Under the sponsorship of the International Extranodal Lymphoma Study Group, a Multidisciplinary Workshop on primary CNS lymphoma (PCNSL) with over 50 participants from Europe, North America, Israel, and Australia was held as part of the Eighth International Conference on Malignant Lymphoma in Lugano, Switzerland (June 12 to 15, 2002). The main purposes of the Workshop were to exchange the latest scientific information, to analyze methodologic issues in the design of clinical trials, to reach a consensus on treatment recommendations and prognostic factors, to discuss clinical and molecular targets for future studies, and to establish an international collaborative group to conduct laboratory and clinical investigations in PCNSL. This article summarizes the contents of the Workshop, analyzes the current knowledge on the most relevant biologic and clinical issues in PCNSL, and focuses on fundamental challenges to be addressed in future studies.

The Workshop on Primary CNS Lymphomas (Lugano, Switzerland, June 11, 2002) has been supported by an educational grant of the European School of Oncology and, in part, by the Swiss Cancer League.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
L. Angelov, N. D. Doolittle, D. F. Kraemer, T. Siegal, G. H. Barnett, D. M. Peereboom, G. Stevens, J. McGregor, K. Jahnke, C. A. Lacy, et al.
Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience
J. Clin. Oncol., July 20, 2009; 27(21): 3503 - 3509.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
M. Linnebank, S. Moskau, A. Jurgens, M. Simon, A. Semmler, K. Orlopp, A. Glasmacher, C. Bangard, M. Vogt-Schaden, H. Urbach, et al.
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma
Neuro-oncol, January 1, 2009; 11(1): 2 - 8.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Hassan, C. G. Stefanoff, F. Felisbino, M. H. M. Barros, I. R. Zalcberg, C. E. Klumb, R. S. Bigni, and H. N. Seuanez
Second Epstein-Barr Virus-Associated Burkitt's Lymphoma of the CNS in a Child With Progressive Renal Failure
J. Clin. Oncol., June 20, 2008; 26(18): 3085 - 3087.
[Full Text] [PDF]


Home page
BloodHome page
N. D. Doolittle, L. E. Abrey, T. N. Shenkier, S. Tali, J. E.C. Bromberg, E. A. Neuwelt, C. Soussain, K. Jahnke, P. Johnston, G. Illerhaus, et al.
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report
Blood, February 1, 2008; 111(3): 1085 - 1093.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. Batchelor and J. S. Loeffler
Primary CNS Lymphoma
J. Clin. Oncol., March 10, 2006; 24(8): 1281 - 1288.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
L. M. DeAngelis and F. M. Iwamoto
An Update on Therapy of Primary Central Nervous System Lymphoma
Hematology, January 1, 2006; 2006(1): 311 - 316.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Domhan, C. Morath, P. Schnulle, R. Waldherr, and M. Zeier
A generalized seizure in a renal allograft recipient
Nephrol. Dial. Transplant., April 1, 2005; 20(4): 834 - 836.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E. A. Neuwelt, P. E. Guastadisegni, P. Varallyay, and N. D. Doolittle
Imaging Changes and Cognitive Outcome in Primary CNS Lymphoma after Enhanced Chemotherapy Delivery
AJNR Am. J. Neuroradiol., February 1, 2005; 26(2): 258 - 265.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. T. Batchelor, B. R. Buchbinder, and N. L. Harris
Case 1-2005 - A 35-Year-Old Woman with Difficulty Walking, Headache, and Nausea
N. Engl. J. Med., January 13, 2005; 352(2): 185 - 194.
[Full Text] [PDF]


Home page
NeurologyHome page
A. M.P. Omuro, L. M. DeAngelis, J. Yahalom, and L. E. Abrey
Chemoradiotherapy for primary CNS lymphoma: An intent-to-treat analysis with complete follow-up
Neurology, January 11, 2005; 64(1): 69 - 74.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. P. O'Neill
Neurocognitive outcomes in primary CNS lymphoma (PCNSL)
Neurology, February 24, 2004; 62(4): 532 - 533.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online